Svimmelhed som bivirkning af farmakologisk behandling

Nanna Borup Johansen; Mahnaz Ayadipanah; Emilie Sofia Sonnenschein; Hanne Rolighed Christensen; Gesche Jürgens

Svimmelhed som bivirkning af farmakologisk behandling

Nanna Borup Johansen, Mahnaz Ayadipanah, Emilie Sofia Sonnenschein, Hanne Rolighed Christensen, Gesche Jürgens

Klinisk Farmakologisk Afd.

Abstrakt

Dizziness is a well-known side effect of a wide range of drugs. However, the side effects reported in the summary of product characteristics are not exclusively based on placebo-controlled trials. Based on a systematic review of the literature including randomised placebo-controlled clinical trials, antihypertensive combination drugs, methylphenidate, high doses of tramadol and serotonin-norepinephrine reuptake inhibitors were associated with an increased risk of dizziness. Antihypertensive monotherapy and selective serotonin reuptake inhibitors were generally not associated with an increased risk of dizziness when compared with placebo.

Bidragets oversatte titel	Dizziness as a side effect of pharmacological therapy
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	175
Udgave nummer	45
Sider (fra-til)	2720-5
Antal sider	6
ISSN	0041-5782
Status	Udgivet - 4 nov. 2013

Emneord

Antidepressive Agents/adverse effects
Antihypertensive Agents/adverse effects
Dizziness/chemically induced
Drug Interactions
Drug Labeling/statistics & numerical data
Drug-Related Side Effects and Adverse Reactions/complications
Humans

Citationsformater

@article{dc9205f4096547be8db41d436203d20c,

title = "Svimmelhed som bivirkning af farmakologisk behandling",

abstract = "Dizziness is a well-known side effect of a wide range of drugs. However, the side effects reported in the summary of product characteristics are not exclusively based on placebo-controlled trials. Based on a systematic review of the literature including randomised placebo-controlled clinical trials, antihypertensive combination drugs, methylphenidate, high doses of tramadol and serotonin-norepinephrine reuptake inhibitors were associated with an increased risk of dizziness. Antihypertensive monotherapy and selective serotonin reuptake inhibitors were generally not associated with an increased risk of dizziness when compared with placebo. ",

keywords = "Antidepressive Agents/adverse effects, Antihypertensive Agents/adverse effects, Dizziness/chemically induced, Drug Interactions, Drug Labeling/statistics & numerical data, Drug-Related Side Effects and Adverse Reactions/complications, Humans",

author = "{Borup Johansen}, Nanna and Mahnaz Ayadipanah and Sonnenschein, {Emilie Sofia} and Christensen, {Hanne Rolighed} and Gesche J{\"u}rgens",

year = "2013",

month = nov,

day = "4",

language = "Dansk",

volume = "175",

pages = "2720--5",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "45",

}

TY - JOUR

T1 - Svimmelhed som bivirkning af farmakologisk behandling

AU - Borup Johansen, Nanna

AU - Ayadipanah, Mahnaz

AU - Sonnenschein, Emilie Sofia

AU - Christensen, Hanne Rolighed

AU - Jürgens, Gesche

PY - 2013/11/4

Y1 - 2013/11/4

N2 - Dizziness is a well-known side effect of a wide range of drugs. However, the side effects reported in the summary of product characteristics are not exclusively based on placebo-controlled trials. Based on a systematic review of the literature including randomised placebo-controlled clinical trials, antihypertensive combination drugs, methylphenidate, high doses of tramadol and serotonin-norepinephrine reuptake inhibitors were associated with an increased risk of dizziness. Antihypertensive monotherapy and selective serotonin reuptake inhibitors were generally not associated with an increased risk of dizziness when compared with placebo.

AB - Dizziness is a well-known side effect of a wide range of drugs. However, the side effects reported in the summary of product characteristics are not exclusively based on placebo-controlled trials. Based on a systematic review of the literature including randomised placebo-controlled clinical trials, antihypertensive combination drugs, methylphenidate, high doses of tramadol and serotonin-norepinephrine reuptake inhibitors were associated with an increased risk of dizziness. Antihypertensive monotherapy and selective serotonin reuptake inhibitors were generally not associated with an increased risk of dizziness when compared with placebo.

KW - Antidepressive Agents/adverse effects

KW - Antihypertensive Agents/adverse effects

KW - Dizziness/chemically induced

KW - Drug Interactions

KW - Drug Labeling/statistics & numerical data

KW - Drug-Related Side Effects and Adverse Reactions/complications

KW - Humans

M3 - Review

C2 - 24629236

VL - 175

SP - 2720

EP - 2725

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 45

ER -

Svimmelhed som bivirkning af farmakologisk behandling

Abstrakt

Emneord

Fingeraftryk

Citationsformater